… ; said Mishra. SBI technical chart Cipla | LTP: ₹1,578.20 … 1,520 Mishra underscored that Cipla is consolidating after a … 1,600 was supported by healthy volume action, highlighting buyers’ … outlook," said Mishra. Cipla technical chart Ashok Leyland | …

… ), SBI Life, Sun Pharma and Cipla were among major gainers on … launched Leqselvi, an anti-alopecia drug, in the US. The … company’s focus on specialty medicines, highlighting the importance of … trust. Governance and Financial Health The insurer also announced the …

… larger, more stable companies. Pharma and Select Stocks Shine … Bright Pharma stocks led the charge … HDFC Life, Sun Pharma, Infosys, and Cipla. These helped push the … in pharma suggests investors are favoring defensive or health‑oriented …

… Sun Pharmaceutical — closed at ₹1,648.5, up 1.8% Cipla — closed …

… for participants." Sun Pharma, Dr Reddy’s, Cipla, Zydus Lifesciences Ltd … regulators face challenges around spurious medicines and cosmetic misuse. The side … of a particular drug," said Biplab Lenin, partner (pharma, healthcare and life …

… weakening demand for Indian pharmaceutical (pharma) drugs in the US — … and Drug Administration observations, while Lupin and Cipla … oncology continue to show healthy demand, supporting overall … reducing reliance on Chinese biotech supply chains, could …

… top losers on September 12 Cipla closed 1.8% lower at … at ₹6,799.0 Sun Pharmaceutical closed 0.9% lower at …

… growing government investments in healthcare infrastructure, and rising screening … Genentech, Inc. Kadmon Pharmaceuticals, LLC Cipla Ltd Mylan Laboratories Limited … infections, technological advancements in drug therapies, and increased awareness …

… global biotech company specializing in the development and manufacture of biosimilar medicines … from the Japanese Ministry of Health, Labor and Welfare. The biosimilars … Pharma (EEA, UK, Switzerland, Canada, Australia and New Zealand), Cipla/Cipla Gulf …

… witnessing steady growth as healthcare providers and pharmaceutical companies focus on … Therapeutics, LLC. Cipla. Merck & Co., Inc. Sun Pharmaceutical Industries Ltd. … While challenges such as rising drug resistance remain significant, opportunities in …